{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T12:56:25Z","timestamp":1776171385072,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008773","name":"Hainan Association for Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008773","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ejmech.2026.118786","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:19:29Z","timestamp":1774397969000},"page":"118786","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery of quinoxaline-chalcone derivatives as covalent colchicine binding site inhibitors for breast and fibrosarcoma treatment"],"prefix":"10.1016","volume":"310","author":[{"given":"Lu","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lige","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqing","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haowen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaochi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yahong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ejmech.2026.118786_bib1","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1042\/BCJ20190123","article-title":"Tubulin heterogeneity regulates functions and dynamics of microtubules and plays a role in the development of drug resistance in cancer","volume":"476","author":"Prassanawar","year":"2019","journal-title":"Biochem. J."},{"issue":"10","key":"10.1016\/j.ejmech.2026.118786_bib2","doi-asserted-by":"crossref","first-page":"R560","DOI":"10.1016\/j.cub.2021.02.035","article-title":"Molecular mechanisms underlying microtubule growth dynamics","volume":"31","author":"Cleary","year":"2021","journal-title":"Curr. Biol."},{"issue":"11","key":"10.1016\/j.ejmech.2026.118786_bib3","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2174\/1389450124666230731094837","article-title":"Microtubules and cell division: potential pharmacological targets in cancer therapy","volume":"24","author":"Sebastian","year":"2023","journal-title":"Curr. Drug Targets"},{"issue":"3","key":"10.1016\/j.ejmech.2026.118786_bib4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/14728222.2024.2341630","article-title":"An update on the development on tubulin inhibitors for the treatment of solid tumors","volume":"28","author":"Yakkala","year":"2024","journal-title":"Expert Opin. Ther. Targets"},{"issue":"11","key":"10.1016\/j.ejmech.2026.118786_bib5","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1080\/13543776.2023.2291390","article-title":"Development of tubulin polymerization inhibitors as anticancer agents","volume":"33","author":"Peerzada","year":"2023","journal-title":"Expert Opin. Ther. Pat."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118786_bib6","article-title":"\u03b2III-tubulin overexpression in cancer: causes, consequences, and potential therapies","volume":"1876","author":"Kanakkanthara","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"issue":"17","key":"10.1016\/j.ejmech.2026.118786_bib7","doi-asserted-by":"crossref","first-page":"13072","DOI":"10.1021\/acs.jmedchem.1c01202","article-title":"X-ray crystallography-guided design, antitumor efficacy, and QSAR analysis of metabolically stable cyclopenta-pyrimidinyl dihydroquinoxalinone as a potent tubulin polymerization inhibitor","volume":"64","author":"Banerjee","year":"2021","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118786_bib8","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1021\/jm501859j","article-title":"Development of a novel class of tubulin inhibitor from desmosdumotin B with a hydroxylated bicyclic B-ring","volume":"58","author":"Nakagawa-Goto","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118786_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113122","article-title":"Insight on [1,3] thiazolo [4,5-e] isoindoles as tubulin polymerization inhibitors","volume":"212","author":"Span\u00f2","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118786_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114744","article-title":"Development of [1,2] oxazoloisoindoles tubulin polymerization inhibitors: further chemical modifications and potential therapeutic effects against lymphomas","volume":"243","author":"Barreca","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118786_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104312","article-title":"Recent advancements in colchicine derivatives: exploring synthesis, activities, and nanoformulations for enhanced therapeutic efficacy","volume":"30","author":"Rubicondo","year":"2025","journal-title":"Drug Discov. Today"},{"issue":"21","key":"10.1016\/j.ejmech.2026.118786_bib12","doi-asserted-by":"crossref","first-page":"19905","DOI":"10.1021\/acs.jmedchem.4c02419","article-title":"Palladium-mediated bioorthogonal system for prodrug activation of N-benzylbenzamide-containing tubulin polymerization inhibitors for the treatment of solid tumors","volume":"67","author":"Li","year":"2024","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118786_bib13","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.drudis.2021.12.001","article-title":"Molecular interactions at the colchicine binding site in tubulin: an X-ray crystallography perspective","volume":"27","author":"Wang","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2026.118786_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107569","article-title":"The cytotoxic natural compound erianin binds to colchicine site of \u03b2-tubulin and overcomes taxane resistance","volume":"150","author":"Yan","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118786_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118021","article-title":"Design and synthesis of novel 4-aryl-2-benzoyl-imidazoles as colchicine binding site inhibitors","volume":"298","author":"Albadari","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118786_bib16","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ejmech.2018.04.011","article-title":"Recent advances in trimethoxyphenyl (TMP) based tubulin inhibitors targeting the colchicine binding site","volume":"151","author":"Li","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118786_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117139","article-title":"Design, synthesis, and antitumor evaluation of quinazoline-4-tetrahydroquinoline chemotypes as novel tubulin polymerization inhibitors targeting the colchicine site","volume":"283","author":"Lai","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118786_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107930","article-title":"Combretastatin A-4 based compounds as potential anticancer agents: a review","volume":"153","author":"Omar","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118786_bib19","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1039\/D3NP00053B","article-title":"Discovery, synthesis, activities, structure-activity relationships, and clinical development of combretastatins and analogs as anticancer drugs: a comprehensive review","volume":"41","author":"Singh","year":"2024","journal-title":"Nat. Prod. Rep."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118786_bib20","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1021\/acs.jmedchem.2c01566","article-title":"Discovery of novel acridane-based tubulin polymerization inhibitors with anticancer and potential immunomodulatory effects","volume":"66","author":"Peng","year":"2022","journal-title":"J. Med. Chem."},{"issue":"17","key":"10.1016\/j.ejmech.2026.118786_bib21","doi-asserted-by":"crossref","first-page":"7877","DOI":"10.1021\/acs.jmedchem.8b00827","article-title":"Structural modification of the 3,4,5-trimethoxyphenyl moiety in the tubulin inhibitor VERU-111 leads to improved antiproliferative activities","volume":"61","author":"Wang","year":"2018","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118786_bib22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4155\/fmc-2022-0212","article-title":"An update on the recent advances and discovery of novel tubulin colchicine binding inhibitors","volume":"15","author":"Weng","year":"2023","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118786_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116079","article-title":"Discovery of novel coumarin-based derivatives as inhibitors of tubulin polymerization targeting the colchicine binding site with potent anti-gastric cancer activities","volume":"265","author":"Tian","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"24","key":"10.1016\/j.ejmech.2026.118786_bib24","doi-asserted-by":"crossref","first-page":"16774","DOI":"10.1021\/acs.jmedchem.2c01595","article-title":"Discovery of novel N-heterocyclic-fused deoxypodophyllotoxin analogues as tubulin polymerization inhibitors targeting the colchicine-binding site for cancer treatment","volume":"65","author":"Leng","year":"2022","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2026.118786_bib25","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1021\/acs.jmedchem.3c01775","article-title":"PM534, an optimized target-protein interaction strategy through the colchicine site of tubulin","volume":"67","author":"Lucena-Agell","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118786_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117202","article-title":"Innovative design and potential applications of covalent strategy in drug discovery","volume":"284","author":"Tang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2026.118786_bib27","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1021\/acs.jmedchem.4c02760","article-title":"Covalent-allosteric inhibitors: do we get the best of both worlds?","volume":"68","author":"Tao","year":"2025","journal-title":"J. Med. Chem."},{"issue":"20","key":"10.1016\/j.ejmech.2026.118786_bib28","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.1074\/jbc.RA118.006325","article-title":"Covalent modification of Cys-239 in \u03b2-tubulin by small molecules as a strategy to promote tubulin heterodimer degradation","volume":"294","author":"Yang","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2026.118786_bib29","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1124\/mol.119.117812","article-title":"The natural compound withaferin A covalently binds to Cys239 of \u03b2-tubulin to promote tubulin degradation","volume":"96","author":"Yang","year":"2019","journal-title":"Mol. Pharmacol."},{"issue":"19","key":"10.1016\/j.ejmech.2026.118786_bib30","doi-asserted-by":"crossref","first-page":"13354","DOI":"10.1021\/acs.jmedchem.3c00517","article-title":"Recent progress on microtubule degradation agents","volume":"66","author":"Zhang","year":"2023","journal-title":"J. Med. Chem."},{"issue":"24","key":"10.1016\/j.ejmech.2026.118786_bib31","doi-asserted-by":"crossref","first-page":"9461","DOI":"10.1074\/jbc.RA117.001658","article-title":"The compound millepachine and its derivatives inhibit tubulin polymerization by irreversibly binding to the colchicine-binding site in \u03b2-tubulin","volume":"293","author":"Yang","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.118786_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112724","article-title":"Discovery of dihydrofuranoallocolchicinoids - highly potent antimitotic agents with low acute toxicity","volume":"207","author":"Shchegravina","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118786_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104793","article-title":"Structure-activity relationships and antiproliferative effects of 1,2,3,4-4H-quinoxaline derivatives as tubulin polymerization inhibitors","volume":"110","author":"Liang","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118786_bib34","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1021\/acs.jmedchem.8b01755","article-title":"Discovery of novel quinoline-chalcone derivatives as potent antitumor agents with microtubule polymerization inhibitory activity","volume":"62","author":"Li","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118786_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116277","article-title":"Discovery of novel urea derivatives as ferroptosis and autophagy inducer for human Colon cancer treatment","volume":"268","author":"Liang","year":"2024","journal-title":"Eur. J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342600231X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342600231X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T12:08:56Z","timestamp":1776168536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342600231X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":35,"alternative-id":["S022352342600231X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118786","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of quinoxaline-chalcone derivatives as covalent colchicine binding site inhibitors for breast and fibrosarcoma treatment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118786","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118786"}}